[Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]
/in International Publications, Pancreatic Cancer /von 2008-07-22 / Zhonghua Yi Xue Za Zhi 2008 Jul;88(28):1956-60Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2008-07-15 / Cancer Res. 2008 Jul;68(14):5955-64TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
/in Hyperthermia, International Publications, Malignant Melanoma /von 2008-07-11 / Cancer Immunol. Immunother. 2009 Mar;58(3):361-71Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
/in International Publications, NSCLC /von 2008-07-11 / Lung Cancer 2009 Feb;63(2):247-50Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)
/in Chronic Virus Hepatitis, International Publications /von 2008-07-10 / J. Viral Hepat. 2008 Nov;15(11):782-9Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
/in Breast Cancer, Dendritic Cells, International Publications /von 2008-07-09 / Vaccine 2008 Aug;26(36):4716-24Regional hyperthermia in high-risk soft tissue sarcomas
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2008-07-01 / Curr Opin Oncol 2008 Jul;20(4):438-43Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells
/in Breast Cancer, International Publications /von 2008-07-01 / J. Immunol. 2008 Jul;181(1):808-21CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
/in Hepatocellular Carcinoma, International Publications /von 2008-07-01 / Hepatology 2008 Jul;48(1):157-68
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution